1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD

The Lancet

Volumn 329, Issue 8545, 1987, Pages

  Kontoghiorghes, GeorgeJ ^a   Sheppard, Lyndon ^a   Aldouri, MaadhA ^a   Hoffbrand, A Victor ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CHELATING AGENT; DEFERIPRONE; DEFEROXAMINE; IRON;

AGED; ANEMIA; APLASTIC ANEMIA; BLOOD AND HEMOPOIETIC SYSTEM; CALCIUM URINE LEVEL; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; ETIOLOGY; HUMAN; INTOXICATION; IRON URINE LEVEL; MAGNESIUM URINE LEVEL; MYELODYSPLASIA; ORAL DRUG ADMINISTRATION; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; THERAPY; ZINC URINE LEVEL;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; CAPSULES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; IRON; IRON CHELATING AGENTS; MALE; NEURAL TUBE DEFECTS; PYRIDONES; SUPPORT, NON-U.S. GOV'T;

EID: 0023214937     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(87)90545-9     Document Type: Article

References (12)

1. Iron chelation with oral desferrioxamine
2. Desferrioxamine suppositories
3. Rhodotorulic add: Investigation of its potential as an iron chelating drug
4. Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA)
5. The status of new iron chelators
6. The design of orally active iron chelators for the treatment of thalassaemia
7. New orally active iron chelators
8. Orally active α-ketohydroxy pyridine iron chelators intended for clinical use: In vivo studies in rabbits
9. Simple synthesis of the potent iron chelators 1-alkyl-3-hydroxy-2-methylpyrid 4-ones
10. Dose response studies using desferrioxamine and orally active chelators in a mouse model
11. Orally active α-ketohydroxy pyridine iron chelators: Studies in mice
12. Structure/iron binding activity of 1-hydroxypyrid-2-one chelators intended for clinical use